Artificial disc device from AxioMed nears trial completion

01/11/2013 | MedCityNews.com

AxioMed Spine expects to complete a pivotal U.S. study of its Freedom Lumbar Disc, which is used to treat patients suffering from degenerative spine disease, before the end of the quarter. The Cleveland company, which has secured $3.6 million in its latest funding round, will use data from the trial to back its FDA clearance application for the device.

View Full Article in:

MedCityNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Executive Officer
UCare Minnesota
Minneapolis, MN